Free Trial
OTCMKTS:ZLDPF

Zealand Pharma A/S (ZLDPF) Stock Price, News & Analysis

Zealand Pharma A/S logo
$62.34 -1.08 (-1.70%)
As of 05/22/2025 11:43 AM Eastern

About Zealand Pharma A/S Stock (OTCMKTS:ZLDPF)

Key Stats

Today's Range
$61.98
$62.34
50-Day Range
$58.87
$83.52
52-Week Range
$57.97
$141.74
Volume
374 shs
Average Volume
947 shs
Market Capitalization
$4.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.

Receive ZLDPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

ZLDPF Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Zealand Pharma appoints Utpal Singh as CSO
See More Headlines

ZLDPF Stock Analysis - Frequently Asked Questions

Zealand Pharma A/S's stock was trading at $102.36 on January 1st, 2025. Since then, ZLDPF shares have decreased by 39.1% and is now trading at $62.34.
View the best growth stocks for 2025 here
.

Zealand Pharma A/S (OTCMKTS:ZLDPF) posted its quarterly earnings data on Thursday, May, 8th. The company reported ($0.67) earnings per share for the quarter, beating analysts' consensus estimates of ($0.77) by $0.10. The company earned $1.14 million during the quarter, compared to analysts' expectations of $248.61 million. Zealand Pharma A/S had a negative trailing twelve-month return on equity of 15.24% and a negative net margin of 1,725.03%.

Shares of ZLDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/08/2025
Today
5/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ZLDPF
Previous Symbol
NASDAQ:ZLDPF
CIK
N/A
Employees
340
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-102,180,000.00
Net Margins
-1,725.03%
Pretax Margin
-1,383.25%

Debt

Sales & Book Value

Annual Sales
$9.09 million
Price / Cash Flow
N/A
Book Value
$4.49 per share
Price / Book
13.88

Miscellaneous

Free Float
N/A
Market Cap
$4.43 billion
Optionable
Not Optionable
Beta
0.92

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:ZLDPF) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners